Porton Pharmasolutions Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 43082671
Damsholtevej 11, Gunderød 2970 Hørsholm
alexandra.pichard.nielsen@portonpharma.com
tel: 51335856
www.portonpharma.com
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | - 958.00 | - 282.06 |
| Employee benefit expenses | -2 954.00 | -3 958.95 |
| EBIT | -3 912.00 | -4 241.01 |
| Other financial income | 70.73 | |
| Other financial expenses | -21.00 | -95.51 |
| Pre-tax profit | -3 933.00 | -4 265.78 |
| Income taxes | 865.00 | 938.00 |
| Net earnings | -3 068.00 | -3 327.78 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Prepayments and accrued income | 1.00 | 1.03 |
| Current other receivables | 110.00 | 14.10 |
| Current deferred tax assets | 865.00 | 1 803.00 |
| Short term receivables total | 976.00 | 1 818.13 |
| Cash and bank deposits | 1 139.00 | 4 124.83 |
| Cash and cash equivalents | 1 139.00 | 4 124.83 |
| Balance sheet total (assets) | 2 115.00 | 5 942.95 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 4 000.00 | 4 000.00 |
| Retained earnings | -3 068.33 | |
| Profit of the financial year | -3 068.00 | -3 327.78 |
| Shareholders equity total | 932.00 | -2 396.11 |
| Non-current liabilities total | ||
| Current trade creditors | 25.00 | 20.00 |
| Current owed to group member | 633.00 | 7 470.45 |
| Other non-interest bearing current liabilities | 525.00 | 848.62 |
| Current liabilities total | 1 183.00 | 8 339.07 |
| Balance sheet total (liabilities) | 2 115.00 | 5 942.95 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.